Delivery Order SPE2DB24D2205-SPE2DB24FDSHM
Award Date
4/9/24
Potential Completion Date
4/10/24
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $31,029.48 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,564,972,960 doses of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine product. The $30,442.50 delivery order contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the primary...
This federal contract award is for the delivery of 4,564,927,672 units of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine product to the Defense Logistics Agency (DLA). The $64,538.10 firm fixed price contract has a completion date of June 18, 2024 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
The U.S. Defense Logistics Agency (DLA) has awarded a $6,088.50 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., to provide the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. The contract has an ultimate completion date of March 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle...
This is a $121,770.00 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,564,287,915 units of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. The award has an ultimate completion date of April 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $7,077.18 contract is for the supply of the MENVEO VACCINE VL 5S pharmaceutical product, with a completion date of February 23, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA, valued at up to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MENVEO vaccine doses. The $7,462.62 contract has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a pharmaceutical and medical supply provider to the Department of Defense, delivering a wide range of medications and medical materials through an...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $30,442.50 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has a ceiling value of $30,442.50 and an ultimate completion date of June 4, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
The Defense Logistics Agency (DLA) awarded a $21,918.60 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4,565,172,559 units of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. This award is under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a $56,667.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, with a completion date of December 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...